Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
<a href="https://www.fiercebiotech.com/pharma/gsks-tesaro-and-licensor-anaptysbio-lock-horns-court-over-jemperli-agreement" hreflang="en">GSK's Tesaro, AnaptysBio lock horns in court over Jemperli agreement</a>
Some four years into Jemperli’s commercial life span, a rift has emerged between GSK subsidiary Tesaro and the potential cancer blockbuster’s original developer, Anapty...
Other news to note for Nov. 24, 2025
Biopharma happenings, including deals and partnerships, and other news in brief: Actimed, Anaptysbio, GSK, Lava, Tesaro, Xoma.